CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
Details:
-
Corporate Authors:
-
Description:Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating
TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force (USPSTF) recommend testing populations that are at increased risk for TB infection. Once the diagnosis of LTBI has been made, health care providers must choose the most appropriate and effective treatment regimen, and make every effort to ensure those persons complete the entire course of treatment for LTBI.
However, if exposed to and infected by a person with multidrug-resistant TB (MDR TB) or extensively drug-resistant TB (XDR TB), preventive treatment may not be an option.
ltbitreatmentoptions_revised.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Pages in Document:3 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-1.30 MB]
